当前位置: 首页 > 欧盟药品上市信息 反馈纠错 帮助中心
欧盟药品上市信息:EMA数据库
-
欧盟药品上市信息:HMA数据库
-

EMA:通过集中审批程序(CP),经欧盟药品管理局批准上市的药品。 

HMA:通过互认可程序(MRP),在欧盟部分成员国批准上市的药品。

更多上市信息请进入各国官网查询

英国(emc)上市药品查询

英国MHRA药品标签说明书

法国上市药品查询

意大利上市药品查询

瑞士上市药品查询

瑞典上市药品查询

德国上市药品信息

更多国家信息请点击此处

商标名 通用名称 中文名称 ATC编码 授权日期 上市许可持有人 市场状态
Abasaglar (previously Abasria) insulin glargine 甘精胰岛素 A10AE04 2014-09-09 Eli Lilly Regional Operations GmbH Authorised
Abilify aripiprazole 阿立哌唑 N05AX12 2004-06-04 Otsuka Pharmaceutical Europe Ltd Authorised
Abilify Maintena aripiprazole 阿立哌唑 N05AX12 2013-11-15 Otsuka Pharmaceutical Europe Ltd Authorised
Ablavar (previously Vasovist) gadofosveset trisodium 钆磷维塞三钠 V08CA 2005-10-03 TMC Pharma Services Ltd. Withdrawn
Abraxane paclitaxel 紫杉醇 L01CD01 2008-01-11 Celgene Europe Ltd ? Authorised
Abseamed epoetin alfa 促红素α B03XA01 2007-08-28 Medice Arzneimittel Pütter GmbH & Co. KG Authorised
Accofil filgrastim 非格司亭 L03AA02 2014-09-18 Accord Healthcare Ltd Authorised
Aclasta zoledronic acid 唑来膦酸 M05BA08 2005-04-15 Novartis Europharm Limited Authorised
Acomplia rimonabant 利莫纳班 A08AX01 2006-06-19 sanofi-aventis Withdrawn
Acrescent memantine hydrochloride / donepezil hydrochloride 盐酸美金刚胺;盐酸多奈哌齐 N06D 2013-02-20 H. Lundbeck A/S Refused
Actelsar HCT telmisartan / hydrochlorothiazide 替米沙坦;氢氯噻嗪 C09DA07 2013-03-13 Actavis Group hf Authorised
Actos pioglitazone 吡格列酮 A10BG03 2000-10-13 Takeda Pharma A/S Authorised
Actraphane insulin human (rDNA) 人胰岛素(rDNA) A10AD01 2002-10-07 Novo Nordisk A/S Authorised
Actrapid human insulin(rDNA) 人胰岛素(rDNA) A10AB01 2002-10-07 Novo Nordisk A/S Authorised
Adasuve loxapine 洛沙平 N05AH01 2013-02-20 Ferrer Internacional s.a. Authorised
Adcetris brentuximab vedotin 维汀-布仑妥昔单抗 L01XC12 2012-10-25 Takeda Pharma A/S Authorised
Adcirca (previously Tadalafil Lilly) tadalafil 他达拉非 G04BE08 2008-10-01 Eli Lilly Nederland B.V. Authorised
Adempas riociguat 利奥西呱 C02KX05 2014-03-27 Bayer Pharma AG Authorised
Adenuric febuxostat 非布司他 M04AA03 2008-04-21 Menarini International Operations Luxembourg S.A. (MIOL) Authorised
Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) 大流行流感疫苗H5N1 J07BB02 2009-10-10 GlaxoSmithKline Biologicals S.A. Authorised